Steffen, I.G.; Weissmann, T.; Rothe, J.H.; Geisel, D.; Chopra, S.S.; Kahn, J.; Hamm, B.; Denecke, T.
Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI? J. Clin. Med. 2021, 10, 98.
https://doi.org/10.3390/jcm10010098
AMA Style
Steffen IG, Weissmann T, Rothe JH, Geisel D, Chopra SS, Kahn J, Hamm B, Denecke T.
Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI? Journal of Clinical Medicine. 2021; 10(1):98.
https://doi.org/10.3390/jcm10010098
Chicago/Turabian Style
Steffen, Ingo G., Thomas Weissmann, Jan Holger Rothe, Dominik Geisel, Sascha S. Chopra, Johannes Kahn, Bernd Hamm, and Timm Denecke.
2021. "Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?" Journal of Clinical Medicine 10, no. 1: 98.
https://doi.org/10.3390/jcm10010098
APA Style
Steffen, I. G., Weissmann, T., Rothe, J. H., Geisel, D., Chopra, S. S., Kahn, J., Hamm, B., & Denecke, T.
(2021). Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI? Journal of Clinical Medicine, 10(1), 98.
https://doi.org/10.3390/jcm10010098